Concizumab, Elranatamab & Talquetamab Among New EU Filings At EMA

 
• By Neena Brizmohun

The European Medicines Agency has started reviewing a new batch of medicines for potential pan-EU marketing approval.

The EMA has begun reviewing EU marketing applications for new drugs • Source: Shutterstock

More from Europe

More from Geography